Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Par Drugs and Chemicals Ltd
Your Vote -
Buy
78.95%
Hold
5.26%
Sell
15.79%
78.95%
19 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
187.57
82
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
82
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Par Drugs and Chemicals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Par Drugs & Chemical - Board Meeting Intimation
-
Par Drugs & Chemical - Structural Digital Database
-
Par Drugs & Chemical has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Par Drugs & Chemical - Updates
-
Par Drugs & Chemical - Disclosure under SEBI Takeover Regulations
-
Par Drugs & Chemical - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Par Drugs & Chemical - Updates
-
Par Drugs & Chemical - Trading Window-XBRL
-
Par Drugs & Chemical - Trading Window
-
Par Drugs & Chemical - Copy of Newspaper Publication
-
Par Drugs & Chemical - Agreements,Contracts,Arrangements,MOU-XBRL
-
Par Drugs & Chemical - Agreements
-
Par Drugs & Chemical - Agreements
-
Par Drugs & Chemical - Outcome of Board Meeting
-
Par Drugs & Chemical - Updates
-
Par Drugs & Chemical - Integrated Filing- Financial
-
Par Drugs & Chemical Q3 net profit down 83.04% at Rs 0.58 cr
-
Par Drugs & Chemical - Outcome of Board Meeting
-
Par Drugs & Chemical - Financial Result Updates
-
Par Drugs & Chemical - Updates
-
Par Drugs & Chemical - Shareholders meeting
-
Par Drugs & Chemical - Slump Sale-XBRL
-
Par Drugs & Chemical - Updates
-
Par Drugs & Chemical - Adoption of new line(s) of business
-
Par Drugs & Chemical - Shareholders meeting
-
Par Drugs & Chemical - Board Meeting Intimation
Key fundamentals
Evaluate the intrinsic value of Par Drugs and Chemicals Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 85.632 | 71.2383 | 59.8772 | 59.8542 | 45.2336 |
| Liabilities | 85.632 | 71.2383 | 59.8772 | 59.8542 | 45.2336 |
| Equity | 12.3046 | 12.3046 | 12.3046 | 6.1523 | 6.1523 |
| Gross Profit | 22.8175 | 18.2073 | 16.2547 | 16.0127 | 9.4486 |
| Net Profit | 14.501 | 11.3341 | 9.2133 | 11.6112 | 4.7649 |
| Cash From Operating Activities | 20.2489 | 13.377 | 7.6152 | 12.085 | 7.6911 |
| NPM(%) | 15.16 | 11.83 | 12.27 | 19.11 | 8.53 |
| Revenue | 95.6404 | 95.7488 | 75.0744 | 60.7513 | 55.8486 |
| Expenses | 72.8229 | 77.5415 | 58.8197 | 44.7385 | 46.3999 |
| ROE(%) | 14.98 | 11.71 | 9.52 | 11.99 | 4.92 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 10 Jul 2020 | 1.25 | 12.5 | 0 | 35 |
Peers
Other companies within the same industry or sector that are comparable to Par Drugs and Chemicals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 825.75 | -1.80 | 11.65 | 0.00 | 1321.50 | 1.39 |
| Lotus Eye Hospital and Institute Ltd | 81.22 | -0.17 | 338.42 | 0.00 | 14.01 | 0.62 |
| Vaishali Pharma Ltd | 13.47 | -1.82 | 449.00 | 0.00 | 2.76 | 0.00 |
| Astec Lifesciences Ltd | 685.90 | -1.03 | 0.00 | 0.00 | -687.11 | 0.00 |
Company Info
The Company was originally incorporated as "Par Drugs and Chemicals Private Limited" at Bhavnagar, Gujarat as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated February 26, 1999 bearing Registration Number 04-35512 of 1998-99 issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli. Subsequently, the Company was converted into a Public Limited Company pursuant to special resolution passed by the members in Extra-ordinary General Meeting of the Company held on October 24, 2018 and the name of the Company was changed to "Par Drugs and Chemicals Limited" and a fresh certificate of incorporation consequent upon Conversion of Private Company to Public Limited dated November 5, 2018 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company is U24117GJ1999PLC035512.KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY1999- Incorporated as a Private Limited Company with the name `Par Drugs and Chemicals Private Limited'1999- Acquisition of the ongoing business of the M/s. Par In Organic2018- Conversion of the Company from Private Limited to Public Limited 2018 -Company converted from Private Limited to Limited. 2019 -The Company has successfully come up with an Initial Public Offer (IPO) of 16,72,000 Equity Shares of face value of 10 each. 2021 -The Company has issued Bonus Shares in the Ratio of 1:1.
The Company was originally incorporated as "Par Drugs and Chemicals Private Limited" at Bhavnagar, Gujarat as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated February 26, 1999 bearing Registration Number 04-35512 of 1998-99 issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli. Subsequently, the Company was converted into a Public Limited Company pursuant to special resolution passed by the members in Extra-ordinary General Meeting of the Company held on October 24, 2018 and the name of the Company was changed to "Par Drugs and Chemicals Limited" and a fresh certificate of incorporation consequent upon Conversion of Private Company to Public Limited dated November 5, 2018 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company is U24117GJ1999PLC035512.KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY1999- Incorporated as a Private Limited Company with the name `Par Drugs and Chemicals Private Limited'1999- Acquisition of the ongoing business of the M/s. Par In Organic2018- Conversion of the Company from Private Limited to Public Limited 2018 -Company converted from Private Limited to Limited. 2019 -The Company has successfully come up with an Initial Public Offer (IPO) of 16,72,000 Equity Shares of face value of 10 each. 2021 -The Company has issued Bonus Shares in the Ratio of 1:1.
Read More
Parent Organisation
Par Drugs & Chemicals Ltd.
Founded
26/02/1999
Managing Director
Mr.Jignesh Vallabhbhai Savani
NSE Symbol
PARBE
FAQ
The current price of Par Drugs and Chemicals Ltd is
The 52-week high for Par Drugs and Chemicals Ltd is
The market capitalization of Par Drugs and Chemicals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Par Drugs and Chemicals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Par Drugs and Chemicals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Par Drugs and Chemicals Ltd shares.
The CEO of Par Drugs and Chemicals Ltd is Mr.Jignesh Vallabhbhai Savani, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
